VINCRISTINE TEVA 1 mg/ml, solution injectable — 1 flacon(s) en verre de 1 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400938818406 -
CIP7
3881840 -
CIS
63115133
What the source publishes
- Holder
- TEVA SANTE
- Active ingredients
- SULFATE DE VINCRISTINE
- Form
- solution injectable
- Package
- 1 flacon(s) en verre de 1 ml
- Routes
- intraveineuse
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2008-09-10
- Prescription
- Prescription or restricted
Names this record is found by
- VINCRISTINE TEVA 1 mg/ml, solution injectable — 1 flacon(s) en verre de 1 ml
- VINCRISTINE TEVA 1 mg/ml, solution injectable
- SULFATE DE VINCRISTINE
Complete source data
{
"cis": "63115133",
"cip7": "3881840",
"form": "solution injectable",
"name": "VINCRISTINE TEVA 1 mg/ml, solution injectable — 1 flacon(s) en verre de 1 ml",
"cip13": "3400938818406",
"holder": "TEVA SANTE",
"routes": [
"intraveineuse"
],
"holders": [
"TEVA SANTE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "6.90",
"authorisedOn": "2008-09-10",
"compositions": [
{
"name": "SULFATE DE VINCRISTINE",
"nature": "SA",
"strength": "1,0 mg",
"linkageNumber": "1",
"substanceCode": "05113",
"dosageReference": "1 ml de solution injectable",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "5.88",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "VINCRISTINE TEVA 1 mg/ml, solution injectable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon(s) en verre de 1 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2009-09-21",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"SULFATE DE VINCRISTINE"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400938818406"